New Drugs in Oncology: Benefits, Risks and Challenges

被引：2

|

作者：

Cella, David ^{[1
]}

Vervoelgyi, Volker ^{[2
]}

Woermann, Bernhard ^{[3
]}

机构：

[1] Northwestern Univ, Dept Med Social Sci, Chicago, IL 60611 USA

[2] Inst Qual & Wirtschaftlichkeit Gesundheitswesen I, Cologne, Germany

[3] Deutsch Gesell Hamatol & Med Onkol DGHO, Berlin, Germany

来源：

ONKOLOGIE | 2013年 / 36卷

关键词：

PATIENT-REPORTED OUTCOMES; PROGRESSION-FREE SURVIVAL; QUALITY-OF-LIFE; FUNCTIONAL ASSESSMENT; CANCER-THERAPY; LUNG-CANCER; END-POINT; RCC;

D O I：

10.1159/000352000

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：12 / 19

页数：8

相关论文

共 50 条

[1] Balancing the benefits and risks of new drugs for MS
不详
LANCET NEUROLOGY, 2011, 10 (06): : 491 - 491
[2] Benefits vs risks of new antiepileptic drugs
Aicardi, J
REVISTA DE NEUROLOGIA, 2000, 31 (04) : 376 - 381
[3] The challenges of new drugs benefits and risks analysis: Lessons from the ximelagatran FDA Cardiovascular Advisory Committee
Boudes, Pol F.
CONTEMPORARY CLINICAL TRIALS, 2006, 27 (05) : 432 - 440
[4] Benefits and risks of antiasthmatic drugs
Tsoi, AN
TERAPEVTICHESKII ARKHIV, 1998, 70 (03) : 81 - 84
[5] THE RISKS AND BENEFITS OF CURRENT AND NEW ANTI-EPILEPTIC DRUGS
RICHENS, A
BRITISH JOURNAL OF CLINICAL PRACTICE, 1988, 42 (03): : 4 - 6
[6] Exploring the Benefits and Risks of AI in Oncology
James, Ted A.
ONCOLOGY-NEW YORK, 2024, 38 (05):
[7] Food challenges, the risks and benefits
Roberts, G.
CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (09): : 1106 - 1107
[8] Biomania: Benefits, Risks, and Challenges
Allen, Jon G.
SMITH COLLEGE STUDIES IN SOCIAL WORK, 2014, 84 (2-3) : 385 - 403
[9] Medical Oncology: new Drugs - Great White Hope with Risks Foreword
Freund, Mathias
Lueftner, Diana
Wilhelm, Martin
ONKOLOGIE, 2013, 36 : 1 - 1
[10] BENEFITS AND RISKS OF NEW ANTIEPILEPTIC DRUGS IN PATIENTS WITH INTELLECTUAL AND MULTIPLE DISABILITIES
Huber, B.
EPILEPSIA, 2009, 50 : 30 - 30

← 1 2 3 4 5 →